Unhappy with your Medicare Advantage? You have one more chance to change your mind. [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Good news — you can make changes during the Medicare Advantage enrollment period running from Jan. 1 to March 31, which allows you to: Most Read from MarketWatch ‘I'll be the bad guy if I reject their offer': My son and his wife want to buy our rental for half the market value. Is that fair to our other children? The stock market has entered the danger zone. How one strategist recommends piloting around it. ‘It feels like retaliation': My sister is estranged from her daughter and wants to donate her inheritance. Is that weird? ‘I don't want to spend my remaining days living hand to mouth': I divorced my husband and remarried. Can I claim his Social Security? Forget Santa: Stock-market bulls look to ‘January barometer' for clues on 2025 Any changes you make will take effect on the first day of the month following your plan's receipt of your request. Read: This retirement expert saved her mom $1,200 on Medicare drugs — and she's got advice for you, too What you need t
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lightning Round: Let Lemonade come down, says Jim Cramer [CNBC]CNBC
- Cramer's Lightning Round: ‘I'd be careful' with Novo Nordisk [CNBC]CNBC
- Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Drug Company to Share Revenues With Indigenous People Who Donated Their Genes [The New York Times]The New York Times
- Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Sanford C. Bernstein from an "underperform" rating to a "market perform" rating.MarketBeat
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 12/20/24 - Form 6-K
- 12/20/24 - Form 6-K
- 12/18/24 - Form 6-K
- NVO's page on the SEC website